Modulation of strategic status signaling: oxytocin changes men's fluctuations of status products preferences in their female partners' menstrual cycle.

IF 3.5 3区 医学 Q2 NEUROSCIENCES
Honghong Tang, Hongyu Fu, Song Su, Luqiong Tong, Yina Ma, Chao Liu
{"title":"Modulation of strategic status signaling: oxytocin changes men's fluctuations of status products preferences in their female partners' menstrual cycle.","authors":"Honghong Tang, Hongyu Fu, Song Su, Luqiong Tong, Yina Ma, Chao Liu","doi":"10.1007/s00213-025-06783-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Women exhibit subtle fluctuations in mating-related behaviors throughout their menstrual cycle, and men are capable of detecting these ovulatory cues. This ability may impact male mating behavior, prompting adjustments in their preferences for consumer products based on these signals. Nonetheless, the potential influence of oxytocin on men's preferences for status products, particularly in the context of their female partners' menstrual cycles, is not yet known.</p><p><strong>Objectives: </strong>This study aims to explore how oxytocin regulates men's responses to their female partners' ovulation in heterosexual romantic relationships by specifically examining changes in their preferences for status consumption.</p><p><strong>Methods: </strong>Through a pilot study (N = 110) and two main studies (N<sub>1</sub> = 789, N<sub>2</sub> = 120), we analyzed how oxytocin influences fluctuations in men's preferences for status products throughout their female partners' menstrual cycles. In Study 1, we examined the impact of the female menstrual cycle on men's preferences for status products. In Study 2, we employed intranasal oxytocin to investigate its modulatory effect on the menstrual cycle's influence.</p><p><strong>Results: </strong>Findings revealed that men demonstrated a lower preference for status products during their partners' ovulation compared to non-ovulatory phases. Furthermore, intranasal oxytocin significantly reduced men's liking for status products during the ovulatory phase, but not during the menstrual phase, with a stronger effect observed among men with a heightened intuitive inclination.</p><p><strong>Conclusions: </strong>These results suggest that men in committed relationships strategically adapt their consumption of status products according to their female partners' menstrual cycles, with oxytocin playing a moderating role in this adaptation and individual differences influencing responses.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-025-06783-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Women exhibit subtle fluctuations in mating-related behaviors throughout their menstrual cycle, and men are capable of detecting these ovulatory cues. This ability may impact male mating behavior, prompting adjustments in their preferences for consumer products based on these signals. Nonetheless, the potential influence of oxytocin on men's preferences for status products, particularly in the context of their female partners' menstrual cycles, is not yet known.

Objectives: This study aims to explore how oxytocin regulates men's responses to their female partners' ovulation in heterosexual romantic relationships by specifically examining changes in their preferences for status consumption.

Methods: Through a pilot study (N = 110) and two main studies (N1 = 789, N2 = 120), we analyzed how oxytocin influences fluctuations in men's preferences for status products throughout their female partners' menstrual cycles. In Study 1, we examined the impact of the female menstrual cycle on men's preferences for status products. In Study 2, we employed intranasal oxytocin to investigate its modulatory effect on the menstrual cycle's influence.

Results: Findings revealed that men demonstrated a lower preference for status products during their partners' ovulation compared to non-ovulatory phases. Furthermore, intranasal oxytocin significantly reduced men's liking for status products during the ovulatory phase, but not during the menstrual phase, with a stronger effect observed among men with a heightened intuitive inclination.

Conclusions: These results suggest that men in committed relationships strategically adapt their consumption of status products according to their female partners' menstrual cycles, with oxytocin playing a moderating role in this adaptation and individual differences influencing responses.

战略地位信号的调节:催产素改变男性在女性伴侣月经周期中对地位产品偏好的波动。
基本原理:女性在整个月经周期中表现出与交配有关的行为的微妙波动,而男性能够探测到这些排卵线索。这种能力可能会影响男性的交配行为,促使他们根据这些信号调整对消费品的偏好。尽管如此,催产素对男性对地位产品偏好的潜在影响,特别是在其女性伴侣的月经周期的背景下,尚不清楚。目的:本研究旨在通过研究男性对地位消费偏好的变化,探讨催产素如何调节异性恋爱关系中男性对女性伴侣排卵的反应。方法:通过一项先导研究(N = 110)和两项主要研究(N1 = 789, N2 = 120),我们分析了催产素在整个女性伴侣月经周期中如何影响男性对地位产品偏好的波动。在研究1中,我们研究了女性月经周期对男性对身份产品偏好的影响。在研究2中,我们采用鼻内催产素来研究其对月经周期的调节作用。结果:研究结果显示,与非排卵期相比,男性在伴侣排卵期对地位产品的偏好较低。此外,鼻内催产素显著降低了男性在排卵期对地位产品的喜爱程度,但在月经期没有,在直觉倾向较高的男性中观察到更强的效果。结论:这些结果表明,处于忠诚关系中的男性会根据女性伴侣的月经周期策略性地调整自己对地位产品的消费,催产素在这种调整中起调节作用,个体差异影响反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psychopharmacology
Psychopharmacology 医学-精神病学
CiteScore
7.10
自引率
5.90%
发文量
257
审稿时长
2-4 weeks
期刊介绍: Official Journal of the European Behavioural Pharmacology Society (EBPS) Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields: Human Psychopharmacology: Experimental This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered. Human Psychopharmacology: Clinical and Translational This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects. Preclinical psychopharmacology: Behavioral and Neural This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels. Preclinical Psychopharmacology: Translational This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways. Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信